InsideHealthPolicy

@InHealthPolicy

offers inside news on federal health and safety regulation. Start a free 30-day trial today:

Arlington, VA
Vrijeme pridruživanja: studeni 2011.

Tweetovi

Blokirali ste korisnika/cu @InHealthPolicy

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @InHealthPolicy

  1. President’s Pledge To Protect Preexisting Conditions Challenged By Democrats

    Poništi
  2. Trump Gives Nod To Grassley’s Drug Pricing Bill; GOP Reaction Mixed

    Poništi
  3. Trump Gives Nod To Grassley’s Drug Pricing Bill; GOP Reaction Mixed

    Poništi
  4. Gottlieb: Senate Finance Bill’s Inflation Rebates Would Spur Higher List Prices

    Poništi
  5. FDA Grants EUA To CDC’s Coronavirus Diagnostic Tests

    Poništi
  6. U.S. Embassy Blasts Drug Pricing In Netherlands As Trump Pushes IPI

    Poništi
  7. Ahead Of FDA’s Flavor Ban, E&C To Discuss E-Cigarette Marketing, Use

    Poništi
  8. Fast Approval Drugs Won’t Get Special Treatment In Closed Formularies

    Poništi
  9. 🆓Read all the stories and features from Inside Health Policy with a free, no-obligation 30-day trial. Get started now:

    Poništi
  10. Gottlieb: Senate Finance Bill’s Inflation Rebates Would Spur Higher List Prices

    Poništi
  11. FDA Issues Nutrition Labeling Compliance Guide For Small Businesses

    Poništi
  12. U.S. Embassy Blasts Drug Pricing In Netherlands As Trump Pushes IPI

    Poništi
  13. CMS Developing Medicare Demonstration To Make Insulin Affordable

    Poništi
  14. Poništi
  15. U.S. Embassy Blasts Drug Pricing In Netherlands As Trump Pushes IPI

    Poništi
  16. 4. velj

    DOJ, GOP Plaintiffs Ask SCOTUS Not To Take Up ACA Case, But Differ On District Outcome

    Poništi
  17. 4. velj

    Idaho’s Enhanced Short-Term Plans Ask Appeals Court To Uphold HHS Rule

    Poništi
  18. 4. velj

    CMS Developing Medicare Demonstration To Make Insulin Affordable

    Poništi
  19. 3. velj

    Governors, Medicaid Chiefs, Providers Want Supplemental Pay Rule Axed

    Poništi
  20. 3. velj

    FDA Guide Aims To Curb False, Misleading Biologic Labeling, Promotion

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·